{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:30Z","timestamp":1792406490839,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960513"],"award-info":[{"award-number":["81960513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103071","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:52:35Z","timestamp":1792000355000},"page":"103071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PiRNA-Hsap_1847317 may serve as a novel biomarker of PD-1 inhibitor resistance in patients with advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"74","author":[{"given":"Mi","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeming","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2026.103071_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100465","article-title":"Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis","volume":"7","author":"Siciliano","year":"2022","journal-title":"ESMo Open."},{"issue":"7","key":"10.1016\/j.tranon.2026.103071_bib0003","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jtho.2016.02.015","article-title":"Predictive markers for the efficacy of Anti-PD-1\/PD-L1 antibodies in lung cancer","volume":"11","author":"Shukuya","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"23","key":"10.1016\/j.tranon.2026.103071_bib0004","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1158\/0008-5472.CAN-24-0658","article-title":"Targeting NTRK1 enhances immune checkpoint inhibitor efficacy in NTRK1 wild-type non-small cell lung cancer","volume":"84","author":"Smith","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000398","article-title":"Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce","volume":"8","author":"Kluger","year":"2020","journal-title":"J. ImmunOther Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2026.103071_bib0006","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41568-021-00376-8","article-title":"Decoding leader cells in collective cancer invasion","volume":"21","author":"Vilchez Mercedes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104683","article-title":"Resistance to PD-1\/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer","volume":"209","author":"Li","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0008","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-022-01586-w","article-title":"The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0009","article-title":"The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy","volume":"12","author":"Budi","year":"2022","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.tranon.2026.103071_bib0010","doi-asserted-by":"crossref","first-page":"R730","DOI":"10.1016\/j.cub.2014.07.037","article-title":"piRNAs","volume":"24","author":"Han","year":"2014","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12967-022-03257-2","article-title":"piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner","volume":"20","author":"Xie","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s43556-025-00368-2","article-title":"Identification of PIWI-interacting RNAs based models for lung adenocarcinoma early detection: a multicenter cohort study","volume":"6","author":"Liang","year":"2025","journal-title":"Mol. Biomed."},{"issue":"5","key":"10.1016\/j.tranon.2026.103071_bib0013","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10528-023-10348-2","article-title":"piRNA-18 inhibition cell proliferation, migration and invasion in colorectal cancer","volume":"61","author":"Liu","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.tranon.2026.103071_bib0014","article-title":"piR-hsa-211106 inhibits the progression of lung adenocarcinoma through pyruvate carboxylase and enhances chemotherapy sensitivity","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0015","first-page":"940","article-title":"Role of piwi-interacting RNA-651 in the carcinogenesis of non-small cell lung cancer","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.tranon.2026.103071_bib0016","article-title":"Targeting piRNA-137463 inhibits tumor progression and boosts sensitivity to immune checkpoint blockade via De novo cholesterol biosynthesis in lung adenocarcinoma","volume":"12","author":"Zhan","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"10.1016\/j.tranon.2026.103071_bib0017","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s13277-015-4056-0","article-title":"piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling","volume":"37","author":"Peng","year":"2016","journal-title":"Tumour. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2478\/abm-2022-0002","article-title":"PIWI-interacting RNA (piRNA): a narrative review of its biogenesis, function, and emerging role in lung cancer","volume":"16","author":"Mukherjee","year":"2022","journal-title":"Asian Biomed. (Res. Rev. News)"},{"issue":"2","key":"10.1016\/j.tranon.2026.103071_bib0019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41580-022-00528-0","article-title":"Emerging roles and functional mechanisms of PIWI-interacting RNAs","volume":"24","author":"Wang","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103071_bib0020","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/CMAR.S209300","article-title":"The emerging roles of PIWI-interacting RNA in human cancers","volume":"11","author":"Yu","year":"2019","journal-title":"Cancer Manage Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-019-1052-9","article-title":"The emerging role of the piRNA\/piwi complex in cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0022","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2147\/CMAR.S193266","article-title":"A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer","volume":"11","author":"Qu","year":"2019","journal-title":"Cancer Manage Res."},{"issue":"5","key":"10.1016\/j.tranon.2026.103071_bib0023","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0024","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/curroncol30010043","article-title":"Correlation between lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and extramural vascular invasion (EMVI) in locally advanced rectal cancer","volume":"30","author":"Gawi\u0144ski","year":"2022","journal-title":"Curr. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2026.103071_bib0025","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/biom13121803","article-title":"Neutrophil-to-lymphocyte ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond","volume":"13","author":"Mosca","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.tranon.2026.103071_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028617","article-title":"The relationship between NLR\/PLR\/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors","volume":"101","author":"Liu","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.tranon.2026.103071_bib0027","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.24448","article-title":"IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer","volume":"125","author":"Rotondo","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1583421","article-title":"Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer","volume":"16","author":"Taylor","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103071_bib0029","article-title":"Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103071_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10408363.2025.2555278","article-title":"Regulatory mechanisms and emerging diagnostic and therapeutic opportunities of non-coding RNAs in tumorigenesis: a pan-cancer perspective","volume":"63","author":"Sandai","year":"2026","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.tranon.2026.103071_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004239","article-title":"Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients","volume":"10","author":"Bruschini","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102812","article-title":"cncFinder: a graph-attention-network-based interpretable learning model to identify bifunctional long non-coding RNAs","volume":"37","author":"Tang","year":"2026","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.tranon.2026.103071_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101215","article-title":"Resistance to immunotherapy in non-small cell lung cancer: unraveling causes, developing effective strategies, and exploring potential breakthroughs","volume":"81","author":"Dong","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"8","key":"10.1016\/j.tranon.2026.103071_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70418","article-title":"A robust machine learning model based on ribosomal-subunit-derived piRNAs for diagnostic potential of nonsmall cell lung cancer across multicentre, large-scale of sequencing data","volume":"15","author":"Gao","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tranon.2026.103071_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101313","article-title":"Dissection of immunotherapeutic predictive versus prognostic transcriptional programs identifies SLC22A5-centric carnitine metabolism-driven resistance to anti-PD-(L)1 treatment in non-small cell lung cancer","volume":"84","author":"Wang","year":"2026","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tranon.2026.103071_bib0036","article-title":"Tracking the response to immunotherapy: blood microRNA dynamics in patients with advanced non-small cell lung cancer","volume":"9","author":"Chiaruttini","year":"2025","journal-title":"JCo Precis. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.103071_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100834","article-title":"Identification of a proteomic signature for predicting immunotherapy response in patients with metastatic non-small cell lung cancer","volume":"23","author":"Mondelo-Macia","year":"2024","journal-title":"Mol. Cell Proteomics."},{"issue":"7","key":"10.1016\/j.tranon.2026.103071_bib0038","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179352","article-title":"Soluble immune-checkpoint factors: a potential immunotherapy biomarker","volume":"134","author":"Tan","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2026.103071_bib0039","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.csbj.2023.10.042","article-title":"Pan-cancer landscape of immunology PIWI-interacting RNAs","volume":"21","author":"Wan","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"7","key":"10.1016\/j.tranon.2026.103071_bib0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmedgenet-2021-108327","article-title":"Disorders and roles of tsRNA, snoRNA, snRNA and piRNA in cancer","volume":"59","author":"Xiao","year":"2022","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tranon.2026.103071_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965684","article-title":"PIWI-interacting RNAs in cancer: biogenesis, function, and clinical significance","volume":"12","author":"Yao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.103071_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216189","article-title":"PIWI-interacting RNAs: critical roles and therapeutic targets in cancer","volume":"562","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0043","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.tranon.2026.103071_bib0044","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641052","article-title":"piRNA-823 is involved in cancer stem cell regulation through altering DNA methylation in association with luminal breast cancer","volume":"9","author":"Ding","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0046","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","article-title":"The epigenetic regulatory mechanism of PIWI\/piRNAs in human cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0047","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"65","key":"10.1016\/j.tranon.2026.103071_bib0048","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6424","article-title":"Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape","volume":"6","author":"Takeuchi","year":"2021","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103071_bib0049","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21873\/invivo.13122","article-title":"Implications of axis inhibition protein 2 in breast cancer progression","volume":"37","author":"Ahn","year":"2023","journal-title":"In. Vivo (Brooklyn)"},{"issue":"12","key":"10.1016\/j.tranon.2026.103071_bib0050","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/biom12121805","article-title":"Alteration of cellular energy metabolism through LPAR2-Axin2 axis in gastric cancer","volume":"12","author":"Ara","year":"2022","journal-title":"Biomolecules"},{"issue":"17","key":"10.1016\/j.tranon.2026.103071_bib0051","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1111\/jcmm.17852","article-title":"Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2","volume":"27","author":"Cao","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.tranon.2026.103071_bib0052","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","article-title":"ALKBH5 Drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy","volume":"165","author":"Zhai","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tranon.2026.103071_bib0053","first-page":"1","article-title":"Nobiletin inhibits non-small-cell lung cancer by inactivating WNT\/\u03b2-catenin signaling through downregulating miR-15-5p","volume":"2021","author":"Han","year":"2021","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"14","key":"10.1016\/j.tranon.2026.103071_bib0054","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.7150\/jca.58522","article-title":"MicroRNA-1246 by targeting AXIN2 and GSK-3\u03b2 overcomes drug resistance and induces apoptosis in chemo-resistant leukemia cells","volume":"12","author":"Xie","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271603","article-title":"Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275\/AXIN2 in natural killer cells","volume":"14","author":"Ou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103071_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920953731","article-title":"EGFR\/c-met and mTOR signaling are predictors of survival in non-small cell lung cancer","volume":"12","author":"Crees","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103071_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004688","article-title":"Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy","volume":"10","author":"Hwang","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2026.103071_bib0058","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-24-1926","article-title":"Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns of acquired resistance to immunotherapy in patients with NSCLC","volume":"31","author":"Mazzaschi","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103071_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013592","article-title":"Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC","volume":"14","author":"Onieva","year":"2026","journal-title":"J. ImmunOther Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2026.103071_bib0060","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tranon.2026.103071_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1489977","article-title":"Biomarkers for immunotherapy resistance in non-small cell lung cancer","volume":"14","author":"Rother","year":"2024","journal-title":"Front. Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:51:33Z","timestamp":1792403493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":61,"alternative-id":["S1936523326004079"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103071","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PiRNA-Hsap_1847317 may serve as a novel biomarker of PD-1 inhibitor resistance in patients with advanced non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103071"}}